BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 33124135)

  • 1. Breast cancer polygenic risk scores in the clinical cancer genetic counseling setting: Current practices and impact on patient management.
    McGuinness M; Fassi E; Wang C; Hacking C; Ellis V
    J Genet Couns; 2021 Apr; 30(2):588-597. PubMed ID: 33124135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Communicating polygenic risk scores in the familial breast cancer clinic.
    Das Gupta K; Gregory G; Meiser B; Kaur R; Scheepers-Joynt M; McInerny S; Taylor S; Barlow-Stewart K; Antill Y; Salmon L; Smyth C; McInerney-Leo A; Young MA; James PA; Yanes T
    Patient Educ Couns; 2021 Oct; 104(10):2512-2521. PubMed ID: 33706980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Women's responses and understanding of polygenic breast cancer risk information.
    Yanes T; Kaur R; Meiser B; Scheepers-Joynt M; McInerny S; Barlow-Stewart K; Antill Y; Salmon L; Smyth C; James PA; Young MA
    Fam Cancer; 2020 Oct; 19(4):297-306. PubMed ID: 32430685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic counselors' experience with reimbursement and patient out-of-pocket cost for multi-cancer gene panel testing for hereditary cancer syndromes.
    Weldon CB; Trosman JR; Liang SY; Douglas MP; Scheuner MT; Kurian A; Schaa KL; Roscow B; Erwin D; Phillips KA
    J Genet Couns; 2022 Dec; 31(6):1394-1403. PubMed ID: 35900261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Personalized Genetic Breast Cancer Risk Estimation With Polygenic Risk Scores on Preventive Endocrine Therapy Intention and Uptake.
    Kim JO; Schaid DJ; Vachon CM; Cooke A; Couch FJ; Kim CA; Sinnwell JP; Hasadsri L; Stan DL; Goldenberg B; Neal L; Grenier D; Degnim AC; Thicke LA; Pruthi S
    Cancer Prev Res (Phila); 2021 Feb; 14(2):175-184. PubMed ID: 33097489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impacts of genesurance considerations on genetic counselors' practice and attitudes.
    Thoreson E; Murphy L; Lemons J; Farach L; Wilson K; Woodson A; Wagner C
    J Genet Couns; 2020 Dec; 29(6):1210-1220. PubMed ID: 32432815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic counselors' perspectives on population-based screening for BRCA-related hereditary breast and ovarian cancer and Lynch syndrome.
    De Simone LM; Arjunan A; Vogel Postula KJ; Maga T; Bucheit LA
    J Genet Couns; 2021 Feb; 30(1):158-169. PubMed ID: 32562467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polygenic risk scores and breast cancer risk prediction.
    Roberts E; Howell S; Evans DG
    Breast; 2023 Feb; 67():71-77. PubMed ID: 36646003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of lived experience on risk perception among women who received a breast cancer polygenic risk score: 'Another piece of the pie'.
    Willis AM; Smith SK; Meiser B; James PA; Ballinger ML; Thomas DM; Yanes T; Young MA
    J Genet Couns; 2021 Jun; 30(3):849-860. PubMed ID: 33470033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polygenic risk score (PRS) and its potential for breast cancer risk stratification.
    Hovhannisyan M; Kleiblová P; Nehasil P; Soukupová J; Zemánková P; Kleibl Z; Janatová M
    Klin Onkol; 2023; 36(3):198-205. PubMed ID: 37353348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A preliminary investigation of genetic counselors' information needs when receiving a variant of uncertain significance result: a mixed methods study.
    Scherr CL; Lindor NM; Malo TL; Couch FJ; Vadaparampil ST
    Genet Med; 2015 Sep; 17(9):739-46. PubMed ID: 25569439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uptake of polygenic risk information among women at increased risk of breast cancer.
    Yanes T; Meiser B; Kaur R; Scheepers-Joynt M; McInerny S; Taylor S; Barlow-Stewart K; Antill Y; Salmon L; Smyth C; Young MA; James PA
    Clin Genet; 2020 Mar; 97(3):492-501. PubMed ID: 31833054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical genetic counseling and translation considerations for polygenic scores in personalized risk assessments: A Practice Resource from the National Society of Genetic Counselors.
    Wand H; Kalia SS; Helm BM; Suckiel SA; Brockman D; Vriesen N; Goudar RK; Austin J; Yanes T
    J Genet Couns; 2023 Jun; 32(3):558-575. PubMed ID: 36617640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer polygenic risk scores: a 12-month prospective study of patient reported outcomes and risk management behavior.
    Yanes T; Meiser B; Kaur R; Young MA; Mitchell PB; Scheepers-Joynt M; McInerny S; Taylor S; Barlow-Stewart K; Antill Y; Salmon L; Smyth C; Betz-Stablein B; James PA
    Genet Med; 2021 Dec; 23(12):2316-2323. PubMed ID: 34341522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilization of breast cancer risk prediction models by cancer genetic counselors in clinical practice predominantly in the United States.
    Park MS; Weissman SM; Postula KJV; Williams CS; Mauer CB; O'Neill SM
    J Genet Couns; 2021 Dec; 30(6):1737-1747. PubMed ID: 34076301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addition of a 161-SNP polygenic risk score to family history-based risk prediction: impact on clinical management in non-
    Lakeman IMM; Hilbers FS; Rodríguez-Girondo M; Lee A; Vreeswijk MPG; Hollestelle A; Seynaeve C; Meijers-Heijboer H; Oosterwijk JC; Hoogerbrugge N; Olah E; Vasen HFA; van Asperen CJ; Devilee P
    J Med Genet; 2019 Sep; 56(9):581-589. PubMed ID: 31186341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards clinical utility of polygenic risk scores.
    Lambert SA; Abraham G; Inouye M
    Hum Mol Genet; 2019 Nov; 28(R2):R133-R142. PubMed ID: 31363735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polygenic risk scores for genetic counseling in psychiatry: Lessons learned from other fields of medicine.
    Eeltink E; van der Horst MZ; Zinkstok JR; Aalfs CM; Luykx JJ
    Neurosci Biobehav Rev; 2021 Feb; 121():119-127. PubMed ID: 33301779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer Genetic Counseling and Testing in an Era of Rapid Change.
    Hooker GW; Clemens KR; Quillin J; Vogel Postula KJ; Summerour P; Nagy R; Buchanan AH
    J Genet Couns; 2017 Dec; 26(6):1244-1253. PubMed ID: 28434142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast Cancer Polygenic-Risk Score Influence on Risk-Reducing Endocrine Therapy Use: Genetic Risk Estimate (GENRE) Trial 1-Year and 2-Year Follow-Up.
    Stan DL; Kim JO; Schaid DJ; Carlson EE; Kim CA; Sinnwell JP; Couch FJ; Vachon CM; Cooke AL; Goldenberg BA; Pruthi S
    Cancer Prev Res (Phila); 2024 Feb; 17(2):77-84. PubMed ID: 38154464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.